Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950170-23-011695
Filing Date
2023-04-04
Accepted
2023-04-04 07:31:37
Documents
3
Period of Report
2023-04-04

Document Format Files

Seq Description Document Type Size
1 6-K 2022_earnings_release_wr.htm 6-K 40716
2 EX-99.1 frln-ex99_1.htm EX-99 188882
3 GRAPHIC img173576535_0.jpg GRAPHIC 11135
  Complete submission text file 0000950170-23-011695.txt   246279
Mailing Address SYCAMORE HOUSE GUNNELS WOOD ROAD, STEVENAGE HERTFORDSHIRE X0 SG1 2BP
Business Address SYCAMORE HOUSE GUNNELS WOOD ROAD, STEVENAGE HERTFORDSHIRE X0 SG1 2BP 44 (0)1438 906870
Freeline Therapeutics Holdings plc (Filer) CIK: 0001810031 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39431 | Film No.: 23795108
SIC: 2836 Biological Products, (No Diagnostic Substances)